Accelerating growth: the double-edged sword of self-reliance
With the world seeking an alternative for China, will India rise to the occasion and indeed be the 'pharmacy to the world'?
N Mahalakshmi - July 26, 2021
Building a future-ready, innovative healthcare industry
India’s scientific excellence provides us the opportunity to achieve self-reliance in pharmaceuticals, biopharma and holistic care
Kiran Mazumdar-Shaw - August 28, 2020
Astec LifeSciences MD Ashok Hiremath sells stock worth ₹165 million
The stock has rallied on the back of strong earnings growth and overall optimism for pharma sector
Shailaja Mohapatra - August 13, 2020
Right Antidote
Laurus Lab founder Satyanarayana Chava increases stake as the stock loses steam post its weak show in Q4FY18
Anushka Gupta - July 10, 2018
Bhavin Shah
Sameeksha Capital's founder is impressed by PSP Projects’ execution and capital efficiency
December 14, 2017
Homesick
Rising chronic illnesses and increasing health insurance coverage will spur domestic pharma industry growth
January 02, 2018
Just what the doctor ordered
The Indian pharma industry has a stellar decadal run and it’s not going to change anytime soon
December 23, 2017
A Growing Appetite
Banking on acquisitions, Torrent Pharma is focused on strengthening its presence in the domestic market
Krishna Gopalan - November 28, 2017
Movers and Shakers
What does the future of the third-party logistics industry look like in a post-GST world?
November 27, 2017
Sankaran Naren
How the price of uncertainty threw up a great bargain in the form of Cadila Healthcare and how his relative bet on NTPC didn’t work out
Khushboo Balani - September 19, 2017
